|
Characteristic
|
mFOLFIRINOX (n = 27)
|
Gemox (n = 22)
|
P value
|
|---|
|
Age
|
|
Median, range
|
58 (41–73)
|
56.5 (36–75)
|
0.817
|
|
Sex
| | |
0.181
|
|
Male
|
15 (55.6)
|
8 (36.4)
| |
|
Female
|
12 (44.4)
|
14 (63.6)
| |
|
ECOG
| | |
0.407
|
|
0
|
13 (48.1)
|
8 (36.4)
| |
|
1
|
14 (51.9)
|
14 (63.6)
| |
|
Primary tumor sites
| | |
0.434
|
|
Intrahepatic
|
16 (59.3)
|
9 (40.9)
| |
|
Hilar
|
9 (33.3)
|
11 (50.0)
| |
|
Distal
|
2 (7.4)
|
2 (9.1)
| |
|
Disease status
| | |
0.276
|
|
Locally advanced
|
6 (22.2)
|
8 (36.4)
| |
|
Metastatic
|
21 (77.8)
|
14 (63.6)
| |
|
Metastatic site
|
|
Liver
|
17 (63.0)
|
13 (59.1)
|
0.782
|
|
Lung
|
5 (18.5)
|
2 (9.1)
|
–
|
|
Bone
|
1 (3.7)
|
0 (0)
|
–
|
|
Other
|
1 (3.7)
|
1 (4.5)
|
–
|
|
CA19–9
|
|
Median, range
|
172.0 (6.5–18,940)
|
151.3 (1.7–26,666)
|
0.680
|
- ECOG Eastern Cooperative Oncology Group
- Data are presented as n (%) for categorical variables and as median (range) for continuous variables
